quick search
Today:
Home Education

More Articles

The World's First IPO of Universal Autonomous Driving Technology Company! WeRide Officially Listed on Nasdaq

Oct 27, 2024

NEW YORK,Oct. 25,2024-- WeRide,the leading global commercial-stage company,was officially listed on the Nasdaq Global Select Market under the ticker symbol "WRD." Upon listing,WeRide became

Along the Silk Road, a man from Jiangxi cycles through 18 countries to Paris for the Olympics

Oct 26, 2024

GANZHOU,China,Oct. 25,2024-- A report fromJiangxi International Communication Center(JXICC): Zhu Zhiwen,an Olympic Cyclist from Ruijin,Jiangxi delivered a shock to the Paris Olympics. With a bicycle,h

The 'Global South' sees new momentum and hope through BRICS: Global Times editorial

Oct 26, 2024

BEIJING,Oct. 25,2024-- On Thursday morning,local time,Chinese PresidentXi Jinping attended the "BRICS Plus" leaders\' dialogue at the Kazan Expo International Exhibition Center,and delivered

UniFab Debuts Powerful 8K Upscaling and Slow Motion Interpolation Frames

Oct 26, 2024

HONG KONG,Oct. 25,2024-- UniFab,the world\'s leading AI video enhancement provider,officially releases its latest innovations: 8K upscaling model and slow motion interpolation frames.

ORTUR Introduces the H20 Laser Engraver with Advanced Visual Algorithms and Safety Features

Oct 26, 2024

NEW YORK,Oct. 25,2024-- ORTUR announces the launch of the H20,a versatile laser engraving machine designed for professional engravers and DIY enthusiasts. The H20 accommodates a wide range of engravin

TASTE-2 World Stroke Congress | Sanbexin ® combined with thrombectomy significantly reduces stroke disability

Oct 26, 2024

NANJING,China,Oct. 25,2024-- On October 24,2024,TASTE-2,a Chinese innovative stroke drug study led by Professor WangYongjun from Beijing Tiantan Hospital,was published in an oral report at the 16th Wo

MicuRx Announces the Successful Completion of Phase 1 Clinical Trial of MRX-5 in Australia

Oct 26, 2024

SHANGHAI,Oct. 25,2024-- Recently,ShanghaiMicuRx Pharmaceutical Co.,Ltd. ("MicuRx",688373.SH) announced the successful completion of Phase I clinical trial of MRX-5 in Australia,a self-develo

Seegene Holds Partner Executive Roundtable with Microsoft, and Springer Nature, Accelerating its Technology-Sharing Initiative

Oct 25, 2024

- The first tri-party executive roundtable was held in London to strengthen synergies for Seegene\'s vision of creating \'a world free from diseases\'

Ampace Shined at All-Energy Australia 2024 - Leading the New Era of All-Scenario Energy Storage through Technology

Oct 25, 2024

MELBOURNE,Australia,Oct. 24,2024-- On October 23rd-24th,Ampace made a grand debut at the All-Energy Australia exhibition with its efficient and reliable energy storage solutions. Leveraging its deep e

Medera Announces Completion of Cohort A and Initiation of Dosing in Cohort B of MUSIC-HFpEF, a Phase 1/2a Clinical Trial Evaluating First-In-Human Gene Therapy SRD-002 for Heart Failure with Preserved Ejection Fraction

Oct 25, 2024

Heart failure is a global pandemic with an estimated 64.3 million cases worldwide,costing over US$100B per year

1 ... 86 87 88 89 90 91 92 ... 130

Quick Search

Official Affairs is a reliable source for the latest regional news, corporate updates, and official announcements, providing unbiased reporting and in-depth insights into corporate affairs.

© OfficialAffairs